Filing Flows › Scientist Home Future Health (SHFH) › Q2 2026
Scientist Home Future Health (SHFH) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 11, 2026
Scientist Home Future Health (SHFH) reported revenue of $84K for the second quarter 2026 (Q2 2026), +167% from a year earlier and -55% from the quarter before. Operating margin was -116.1%, net loss $98K (116.1% of revenue).
Scientist Home Future Health, Q2 2026: revenue $84K (+167% year over year), operating margin -116.1%, net loss $98K, operating cash flow −$13K. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $84K | -55% | +167% |
| Operating profit | −$98K | — | — |
| Net earnings | −$98K | — | — |
| Operating cash flow | −$13K | — | — |
What changed
Revenue was $84K in Q2 2026, up 167% year over year and down 55% from the previous quarter. Others (Delivery Fee) was the largest line at 45% of revenue. Others (Delivery Fee) added $38K year over year (up 10230%), 71% of the total change. Scientist Home Mixed Gelatine Hydrolysate declined 40%.
Gross margin was 34.5%, down 8.4 points from Q2 2025. Operating costs exceeded revenue by $98K, an operating margin of -116.1%. Operating expenses grew 146% against revenue growth of 167%. The quarter ended with a net loss of $98K, narrower than the previous quarter's $102K loss.
Operating cash flow was −$13K. Non-cash charges added back $4K of depreciation. Working capital and other items added $81K.
Questions
What was Scientist Home Future Health's revenue in the second quarter 2026?
Scientist Home Future Health (SHFH) reported revenue of $84K for the second quarter 2026 (Q2 2026), +167% from a year earlier and -55% from the quarter before.
Was Scientist Home Future Health profitable in the second quarter 2026?
Operating loss was $98K (-116.1% of revenue) and net loss $98K.